Sitemap EUCAST - Home About EUCAST Organisation Steering Committee General Committee EUCAST Statutes National AST Committees (NAC) Network Laboratories Development Laboratories (EDL) Subcommittees Antimycobacterial Susceptibility Testing (AMST) Antifungal Susceptibility Testing (AFST) Veterinary…
Get to know morePublic Consultations Public consultation is part of the EUCAST decision process. The consultation period is 4 - 12 weeks, and the dates of the beginning and end of the period is clearly stated. Current public consultations Subject Deadline Description Carbapenems Breakpoint Consultation 15 March…
Get to know moreAbout Clinical Breakpoint Tables Clinical breakpoints are for everyday use to advise on patient therapy. Breakpoint tables are updated on the 1st of January each year. Tentative new tables are published in early December - this is for consultation and to permit laboratories to prepare for changes.…
Get to know moreWhen there are no breakpoints? When there are no breakpoints? Guidance document, 29 September 2024 Download PDF Sometimes breakpoints for a species and/or an agent are lacking in EUCAST tables. This may happen because data to allow setting breakpoints is lacking, especially for rare species;…
Get to know moreDocument Archive Breakpoint tables QC tables Guidance documents Expert rules Rationale documents Disk diffusion methodology Media Preparation Disk diffusion validation RAST Expected phenotypes Broth microdilution Clinical breakpoints (v 15.0) - file for printing (1 January 2025 - 31 December 2025)…
Get to know moreClinical Breakpoint Tables Breakpoints are part of a system for categorizing microorganisms as: Susceptible (S) Susceptible, increased exposure (I) Resistant (R) To antimicrobial agents approved for use in the treatment of infectious diseases. Information of the structure of the tables and how they…
Get to know moreDevelopment of Clinical Breakpoints and ECOFFs These pages collate information on the definition of clinical breakpoints and the process of setting MIC breakpoints. Background information is given in the Rationale Documents and in Public Consultations and the MIC:ZD (MIC vs. zone diameter)…
Get to know moreSetting Breakpoints Breakpoints for phenotypic antimicrobial susceptibility testing have been determined by breakpoint committees and as part of regulatory processes for the approval of new drugs since the 1970s. Knowledge of dosage, modes of administration, target infections and clinical outcome…
Get to know moreClinical breakpoint table (Yeast and moulds) Breakpoints and methods for susceptibility testing of yeasts, moulds and dermatophytes are developed and validated by the EUCAST subcommittee on AFST. Document Description Clinical breakpoints for fungi v. 12.0 PDF file for printing; valid from 26 June,…
Get to know moreDocument Archive Breakpoint tables for fungi QC tables Methodology Rationale documents Clinical breakpoints for fungi (v 11.0) - pdf file for printing (until 26 June, 2025) Clinical breakpoints for fungi (v 11.0) - excel file for screen (until 26 June, 2025) Clinical breakpoints for fungi (v 10.0) -…
Get to know more